Paul Saladino· MD
if LDL cholesterol doesn't lead directly to atherosclerosis then we have a major problem with a multi-billion dollar Statin industry
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
if LDL cholesterol doesn't lead directly to atherosclerosis then we have a major problem with a multi-billion dollar Statin industry
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
The cholesterol lowering industry or the fear of cholesterol is a, you know, it's a trillion dollar business at least. You know, we know that the total sales of statin drugs have been, you know, in the order of a trillion dollars.
wow you know we know that the total sales of statin drugs have been you know in the order of a trillion dollars and and that's extraordinary when you think about it